An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma

Devika R. Rao, Wanda Phipatanakul

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Asthma is the most common pediatric chronic disease and is characterized by lung inflammation. Fractional exhaled nitric oxide (FeNO) is thought to reflect the presence of eosinophilic airway inflammation, and is an easy, non-invasive test that has held promise in providing additional objective data. However, not all studies have shown a clinical benefit in the use of FeNO to guide management of asthma in children. This review will describe the results of the most recent studies examining the use of FeNO in the diagnosis and treatment of asthma in infants, preschool-aged children and in school-aged children. It will aid the clinician in providing a clinical context in which FeNO may be most useful in treating pediatric asthma.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalExpert Review of Clinical Immunology
DOIs
StateAccepted/In press - Feb 21 2016

Fingerprint

Nitric Oxide
Asthma
Pediatrics
Preschool Children
Pneumonia
Chronic Disease
Inflammation
Therapeutics

Keywords

  • Fractional exhaled nitric oxide
  • infant lung function
  • lung function
  • pediatric asthma
  • sickle cell disease

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma. / Rao, Devika R.; Phipatanakul, Wanda.

In: Expert Review of Clinical Immunology, 21.02.2016, p. 1-10.

Research output: Contribution to journalArticle

@article{c6f099a2f9384dbc8e8e016ca74edceb,
title = "An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma",
abstract = "Asthma is the most common pediatric chronic disease and is characterized by lung inflammation. Fractional exhaled nitric oxide (FeNO) is thought to reflect the presence of eosinophilic airway inflammation, and is an easy, non-invasive test that has held promise in providing additional objective data. However, not all studies have shown a clinical benefit in the use of FeNO to guide management of asthma in children. This review will describe the results of the most recent studies examining the use of FeNO in the diagnosis and treatment of asthma in infants, preschool-aged children and in school-aged children. It will aid the clinician in providing a clinical context in which FeNO may be most useful in treating pediatric asthma.",
keywords = "Fractional exhaled nitric oxide, infant lung function, lung function, pediatric asthma, sickle cell disease",
author = "Rao, {Devika R.} and Wanda Phipatanakul",
year = "2016",
month = "2",
day = "21",
doi = "10.1586/1744666X.2016.1141049",
language = "English (US)",
pages = "1--10",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",

}

TY - JOUR

T1 - An Overview of Fractional Exhaled Nitric Oxide and Children with Asthma

AU - Rao, Devika R.

AU - Phipatanakul, Wanda

PY - 2016/2/21

Y1 - 2016/2/21

N2 - Asthma is the most common pediatric chronic disease and is characterized by lung inflammation. Fractional exhaled nitric oxide (FeNO) is thought to reflect the presence of eosinophilic airway inflammation, and is an easy, non-invasive test that has held promise in providing additional objective data. However, not all studies have shown a clinical benefit in the use of FeNO to guide management of asthma in children. This review will describe the results of the most recent studies examining the use of FeNO in the diagnosis and treatment of asthma in infants, preschool-aged children and in school-aged children. It will aid the clinician in providing a clinical context in which FeNO may be most useful in treating pediatric asthma.

AB - Asthma is the most common pediatric chronic disease and is characterized by lung inflammation. Fractional exhaled nitric oxide (FeNO) is thought to reflect the presence of eosinophilic airway inflammation, and is an easy, non-invasive test that has held promise in providing additional objective data. However, not all studies have shown a clinical benefit in the use of FeNO to guide management of asthma in children. This review will describe the results of the most recent studies examining the use of FeNO in the diagnosis and treatment of asthma in infants, preschool-aged children and in school-aged children. It will aid the clinician in providing a clinical context in which FeNO may be most useful in treating pediatric asthma.

KW - Fractional exhaled nitric oxide

KW - infant lung function

KW - lung function

KW - pediatric asthma

KW - sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=84958767993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958767993&partnerID=8YFLogxK

U2 - 10.1586/1744666X.2016.1141049

DO - 10.1586/1744666X.2016.1141049

M3 - Article

C2 - 26757849

AN - SCOPUS:84958767993

SP - 1

EP - 10

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

ER -